Home > Links > Corrections > HP

May 2008

May

Corrections

The latest meeting in the “Safety of injectable medicines — implementing the NPSA alert” programme took place on 5 March 2008, not on 20 March (Hospital Pharmacist 2008;15:144).

Patients undergoing minor surgical procedures, who are taking anticoagulants and have a stable INR between 2–4, do not need alter the dose of their anticoagulant. In last month’s Special feature, the attempt to emphasise the importance of not stopping oral anticoagulation for such procedures may have led readers to believe a dose adjustment is always necessary (Hospital Pharmacist 2008;15:130).

April 2008

April

Clarification
The following points from Steve Acres’ presentation at the Hospital Pharmacist conference (2008;15:94–5) are clarified.


A major reason for the hospital failing to retain band 6 pharmacists was the attractiveness of community pharmacy wages, not just the requirement to do night shifts.

Technicians are joining pharmacists on evening and weekend shifts, not on night shifts as stated in the report.

Newly prescribed drugs do not always arrive on the ward within five to 10 minutes, although this is possible.

March 2008

March

Correction
Joanne Taylor is lead technician at Jamieson’s Pharmacy, Birkenhead, Merseyside, not as stated in the report of the Association of Pharmacy Technicians (UK) conference published in the December 2007 issue of Hospital Pharmacist (p382).

January 2008

January

Corrections — drug withdrawal feature
There were two errors in the special feature on drug withdrawal in last month’s Hospital Pharmacist.

If an antidepressant is to be stopped and the patient is not switching to another drug, it is generally recommended to taper the dose over four to six weeks, not as stated in the article (p367).

Tricyclic antidepressants should be withdrawn at least one week before moclobemide is started, not one week before stopping moclobemide, as stated in the article (p368, Panel 1).

PDF (60K)

January 2007

January

Implementation of the Supply Chain Excellence Programme is ongoing, and not at the dates specified in last month’s Hospital Pharmacist special feature (p398, Panel 2 (PDF 280K))

October 2006

October

Krishna Patel was lead author in “Acromegaly — treatment options and management” (Hospital Pharmacist 2006; 13:281–8) and not as listed.

June 2006

June

David Rosser is a consultant in intensive care medicine at University Hospital Birmingham NHS Foundation Trust, not Bristol as stated in a meeting report last month (2006;13:183).

April 2006

April

SMART software The e-mail address for Hayley Wickens, for obtaining further details about SMART software is
hayley.wickens@st-marys.nhs.uk
(Hospital Pharmacist 2006;13:131 PDF (50K))

March 2006

March

NICE implementation The article entitled “NICE implementation — overcoming the barriers” that appeared in the March issue of Hospital Pharmacist (2006;13:95–97 PDF (50K)) was co-authored by Richard Baird, senior business and finance manager at the Countess of Chester NHS Foundation Trust.

November 2005

November

In the special feature on “Radiopharmacy — problems encountered with the products” (PDF 90K), in the September issue of Hospital Pharmacist, the third sentence of the last paragraph in the second column (p305) should have read: “The whole body dose received after the injection of a technetium-99m (99mTc) radiopharmaceutical is in the order of 1.2 to 5.4mGy.” In Panel 1 (p306), the total dose of radioactivity (mGy) for the whole body entry should have read 1.12 mGy for 80 MBq injected Tc-99m pertechnetate, and 1.78x104 mGy (35% thyroid uptake) for 740 MBq I-131 sodium iodide injected. The reference for these figures is: Valentin DJ. Biokinetic models, absorbed doses, and effective doses for individual radiopharmaceuticals. Annals of the ICRP 1998;28(3):116-118.

This error has been taken into account on marking entries for the September Life-long Learning series.

September 2005

September

Some of the reference citations in the text of the article on pluronic lecithin organogel (PDF 100K) in the July/August issue were incorrect. The first mention of reference 21 on p268 should actually be reference 17. In Table 1, references 21–8 should be 17–24 respectively.

July/August 2005

July/August

Reference 3 on p232 (PDF 40K) of the June issue was from the Australian Journal of Hospital Pharmacy and not as stated.

Mark Howell’s e-mail address is mark.howells@burtonh-tr.wmids.nhs.uk, and not as stated on p197 of the June issue.


The answer to question 5e on the May Life-long Learning was false. Some of the answer sheets that were sent out incorrectly identified the answer to this question.

Certificates received by 4 July will have an error of 1 in the score, depending on the answer given to 5e. Scores will be corrected in the database that is used to record scores.

January 2005

January

The picture on p449 of the December issue is David Webb (PDF 210K) and not as described. A printing error distorted the website on p462 (PDF 90K). It is www.imperial.ac.uk/p4578.htm

Also in the December issue, the final line in the first paragraph of p471 (PDF 180K) should be replaced by: It could be a faster and less expensive approach to develop Legacy pharmacy computer systems to support this type of web platform than to change such systems to enable e-procurement. Messaging services and the web platforms can combine to reduce the cost of messaging currently provided by value-added networks.

December 2004

December

Lucy Burrow is chief pharmacist for the acute services division at NHS Tayside, Ninewells Hospital, Dundee and not as described on p436 of the November issue of Hospital Pharmacist.